Addison Advisors LLC Has $47,000 Holdings in Haleon plc (NYSE:HLN)

Addison Advisors LLC grew its position in Haleon plc (NYSE:HLN) by 28.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,954 shares of the company’s stock after purchasing an additional 1,106 shares during the quarter. Addison Advisors LLC’s holdings in Haleon were worth $47,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in HLN. FMR LLC grew its position in shares of Haleon by 5.8% in the third quarter. FMR LLC now owns 104,918,269 shares of the company’s stock valued at $1,110,035,000 after purchasing an additional 5,768,117 shares during the last quarter. Wellington Management Group LLP grew its position in shares of Haleon by 49.9% in the third quarter. Wellington Management Group LLP now owns 9,152,490 shares of the company’s stock valued at $96,833,000 after purchasing an additional 3,046,841 shares during the last quarter. JPMorgan Chase & Co. grew its position in shares of Haleon by 25.3% in the third quarter. JPMorgan Chase & Co. now owns 5,084,202 shares of the company’s stock valued at $53,791,000 after purchasing an additional 1,026,939 shares during the last quarter. Natixis Advisors LLC grew its position in shares of Haleon by 142.5% in the third quarter. Natixis Advisors LLC now owns 1,473,767 shares of the company’s stock valued at $15,593,000 after purchasing an additional 866,070 shares during the last quarter. Finally, Van ECK Associates Corp grew its position in shares of Haleon by 13.5% in the fourth quarter. Van ECK Associates Corp now owns 3,509,400 shares of the company’s stock valued at $33,480,000 after purchasing an additional 418,609 shares during the last quarter. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Stock Up 0.0 %

NYSE HLN opened at $10.16 on Wednesday. The business has a fifty day moving average price of $9.57 and a two-hundred day moving average price of $9.83. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. Haleon plc has a fifty-two week low of $7.89 and a fifty-two week high of $10.80. The stock has a market capitalization of $45.97 billion, a PE ratio of 29.87, a PEG ratio of 2.82 and a beta of 0.28.

Analyst Ratings Changes

Several brokerages recently issued reports on HLN. Sanford C. Bernstein cut Haleon from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 8th. Morgan Stanley cut Haleon from an “overweight” rating to an “equal weight” rating in a research note on Friday, January 10th. Three analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $10.95.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.